At the news
? NEUTRALIMPACT 3/10 6-K filed Aug 25, 2026 at 07:03 ET
AstraZeneca priced a €2.55 billion bond offering across four tranches via its subsidiary AstraZeneca Finance LLC, with proceeds for general corporate purposes. The debt issuance is routine for a company of this size and does not signal a change in credit profile or financial strategy.
- AstraZeneca priced €2.55 billion in Eurobonds across four tranches on 24 August 2026.
- Tranches: €700M at 3.402% due 2030, €600M at 3.652% due 2032, €500M at 3.923% due 2035, €750M at 4.169% due 2038.
- Issued by AstraZeneca Finance LLC and guaranteed by AstraZeneca PLC; expected to close 1 September 2026.
- Net proceeds to be used for general corporate purposes.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access